Devgen nv and Dogal A.S. receive regulatory approval in Turkey for
the use of Devgen's nematicide pr
(Thomson Reuters ONE) - Zwijnaarde, Belgium and Instanbul, Turkey, October 30, 2009Devgen nv (Euronext Brussels: DEVG) and Dogal A.S. today announcedthe approval by the Turkish Ministry of Agriculture for the use ofDevgen's nematicide Devguard® in eggplant and pepper under protectivecover .The product will be launched today for use in eggplant and peppers toallow growers to use the product during this season, which just setoff.This approval comes on top of the regulatory approval receivedearlier for the use of Devguard® in tomatoes and cucumbers underprotective cover. Devguard® is available on the Turkish market sinceAugust this year."Until today, Turkish undercover eggplant and pepper growers lacked anematicide which they could use through the growing season, withoutresidue problem in the final product. We are now pleased to launchsuch a nematicides which fulfils all the expectations of growers andconsumers while protecting their crops against nematode damagethroughout the full growing season," says Ferhan Tezcan, CEO of DogalA.S."We now have the regulatory approval for the use of Devguard® on fourof the most important vegetable crops grown under protective cover",says Thierry Bogaert, CEO of Devgen nv. "This approval is aconfirmation of the applicability of our product to a wider range ofcrops and of the broad spectrum of opportunities that exist for theproduct."About Dogal A.S.Dogal A.S. was established in 1994 by founders with 32 years ofexperience in plant protection. The company's primary mission is toprovide quality products and technical support to Turkish farmers.Dogal A.S. distributes more than 150 licensed pesticides, plantgrowth regulators, single nutrient fertilizers, sun screening product and other supporting materials used in agriculture. Dogal A.S.produces quality products at its high-standard factory in the AntalyaOrganized Industrial Zone, with manufacturing licenses from theMinistry of Agriculture and Rural Affairs, and SL, EC, SC, WP, SP,Tablet and Powder, manufacturing and filling lines. Dogal A.S.'sproducts are controlled and approved by an internal quality controllab before their introduction to the market. Dogal A.S. serves 1250customers throughout Turkey and employs over 90 people. Dogal A.S. isa farmer oriented company providing technical pre and post salesservice support.For more information please contact:Ferhan Tezcan, CEO Dr.M.Necdet Yabas Marketing Development ManagerTel. +90.216.308.65.87 Tel.+90.533.275.64.52ferhantezcan(at)dogaltrm.com necdetyabas(at)dogaltrm.comor visit: www.dogaltrm.comAbout DevgenDevgen's mission is to enable farmers to sustainably grow more foodon less land, with less water, agrochemicals and labor.Devgen uses advanced biotechnology and molecular breeding technologyto make high yielding seeds and crop protection solutions with asuperior environmental profile.Devgen brings this technology to the market in the world's major foodand feed crops through two complementary strategies:- Licensing Devgen technology for use in corn, cotton and soy andselected other crops in exchange for R&D funding, and milestone androyalty payments.- Producing and selling its premium hybrid seeds in major field cropssuch as rice, sunflower, sorghum, and pearl millet, in the Indiansubcontinent and S.E. Asia.In its Crop Protection unit, Devgen developed and has taken to marketa novel nematicide, an agro-chemical product that protects crops fromdamage by parasitic nematodes.Incorporated in 1997, Devgen has offices in Ghent (Belgium),Singapore, Hyderabad (India) and Delaware (US) and employs more than200 people.For more information please contact:Thierry Bogaert, CEO Wim Goemaere, CFOTel. +32 9 324 24 24 Tel. +32 9 324 24 24Thierry.Bogaert(at)devgen.com Wim.Goemaere(at)devgen.comOr visit: www.devgen.comThis press release may contain forward-looking statements containingthe words "anticipates", "expects" , "intends", "plans", "estimates","may" and "continues" as well as similar expressions. Such forwardlooking statements may involve known and unknown risks, uncertaintiesand other factors which might cause the actual results, performanceor achievements of Devgen to be materially different from any futureresults or achievements expressed or implied by such forward-lookingstatements. Factors that could cause or contribute to suchdifferences include, among others: agricultural risks anddifficulties, including weather factors, diseases and pests, thecosts and requirements of regulatory compliance and the speed withwhich approvals are received; public acceptance of biotechnologyproducts; political, economic and social developments in countrieswhere Devgen operates and other risks and factors detailed in thecompany's most recent annual report.These forward looking statements speak only as of the date ofpublication of this document. Devgen disclaims any obligation toupdate such forward looking statements in this document to reflectany change in its expectations, conditions or circumstances on whichsuch statement is based, unless required by law or regulation. Thisdocument does not constitute, or form part of, any offer orinvitation to sell or issue, or any solicitation of any offer, topurchase or subscribe for any securities issued by Devgen NV.http://hugin.info/135721/R/1351340/326535.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 30.10.2009 - 07:00 Uhr
Sprache: Deutsch
News-ID 7647
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 361 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Devgen nv and Dogal A.S. receive regulatory approval in Turkey for
the use of Devgen's nematicide pr"
steht unter der journalistisch-redaktionellen Verantwortung von
Devgen (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
